v3.25.2
Nika BioTechnology, Inc Consolidated Financial Statement (Details) - Nika BioTechnology, Inc.
3 Months Ended
Mar. 31, 2025
USD ($)
Business Acquisition [Line Items]  
Cash $ 322
Inventory 17,007
Accruals (3,833)
Due to related parties (109,877)
Additional paid in capital (5,388,284)
Accumulated Deficit 5,464,629
General and administrative expenses $ 20,036